Weekly Roundup for DECEMBER 30, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Best Wishes for the Holiday Season from the MGH Center for Women’s Mental Health
Best wishes for the holiday season from the Center for Women's Mental Health.
Buprenorphine or Methadone: Which One is Better for the Treatment of Opioid Use Disorder in Pregnancy?
Treatment with buprenorphine versus methadone during pregnancy is associated with lower risk of preterm birth, low birth weight, small size for gestational age, and NAS.
Weekly Roundup for DECEMBER 9, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes
The largest study to date observes no increase in risk of autism or ADHD in children with prenatal exposure to benzodiazepines.
Essential Reads: Peer Support Interventions for Perinatal Depression
Peer support interventions can reduce the incidence of postpartum depression and the severity of depressive symptoms.
Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety
All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.
Toward a Better Understanding of Opioid Use During Pregnancy
Opioid use during pregnancy co-occurs with other variables that are associated with worse outcomes in children, specifically maternal depression and the use of alcohol, tobacco, and other drugs.
Happy Thanksgiving from the MGH Center for Women’s Mental Health
Happy Thanksgiving from the MGH Center for Women's Mental Health
Suicidal Ideation Common in Women Seeking Treatment for Premenstrual Dysphoric Disorder
In this population seeking treatment for PMDD, suicidal ideation is very common, affecting about 40% of the women.